Related Experiment Video

Updated: Jun 1, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Unleashing Chk1 in cancer therapy

Laura Carrassa1, Giovanna Damia

  • 1Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. laura.carrassa@marionegri.it

Cell Cycle (Georgetown, Tex.)
|May 26, 2011
PubMed

Insights

Checkpoint kinase 1 (Chk1) is crucial for DNA damage response and cell cycle control. Inhibiting Chk1 shows promise in cancer therapy, especially when combined with other treatments or in specific genetic contexts.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Checkpoint kinase 1 (Chk1) is a key regulator in DNA damage response pathways.
  • Chk1 activation controls multiple cell cycle checkpoints, ensuring genomic stability.
  • Chk1 plays a vital role in DNA replication and cell division in both normal and cancer cells.

Purpose of the Study:

  • To review the primary functions of Chk1.
  • To summarize the preclinical and clinical development of Chk1 inhibitors.
  • To explore novel therapeutic strategies involving Chk1 inhibitors.

Main Methods:

  • Literature review of Chk1 functions and inhibitor development.
  • Analysis of experimental data on Chk1's role in cellular processes.
  • Evaluation of clinical trial data for Chk1-targeting agents.

Main Results:

  • Chk1 is essential for maintaining genomic stability through cell cycle checkpoint activation.
  • Chk1 inhibitors are being developed for combination cancer therapy, particularly for tumors with defective G1 checkpoints.
  • Chk1's role extends to unstressed conditions, impacting DNA replication and cell division.

Conclusions:

  • Chk1 inhibitors represent a promising therapeutic avenue, either as single agents or in combination therapies.
  • The synthetic lethality approach may identify specific genetic backgrounds where Chk1 inhibitors are highly effective.
  • Further research into Chk1 inhibition could lead to novel cancer treatment strategies.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...